Beijing Tri Prime Gene Pharmaceutical Co (BJSE:920344) Short Percentage of Float

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920344 Beijing Tri Prime Gene Pharmaceutical Co Ltd BJSE:920344
77 GF Score
Price ¥18.55
GF Value ¥25.94
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Beijing Tri Prime Gene Pharmaceutical Co Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BJSE:920344 vs VRTX, REGN, RVMD: Short Percentage of Float Comparison

For the Biotechnology subindustry, Beijing Tri Prime Gene Pharmaceutical Co's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beijing Tri Prime Gene Pharmaceutical Co Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Tri Prime Gene Pharmaceutical Co's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Beijing Tri Prime Gene Pharmaceutical Co's Short Percentage of Float falls into.


BJSE:920344
77GF Score
Beijing Tri Prime Gene Pharmaceutical Co Ltd BJSE:920344
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Beijing Tri Prime Gene Pharmaceutical Co (BJSE:920344) Overvalued in 2026?

Based on GuruFocus' analysis, Beijing Tri Prime Gene Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥18.55 is trading 28.5% below its estimated GF Value™ of ¥25.94. GuruFocus considers Beijing Tri Prime Gene Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for BJSE:920344:

  • Short Percentage of Float:
  • GF Value™: ¥25.94 vs. price of ¥18.55 (28.5% below fair value)
  • GF Score™: 77/100 with 7 warning signs

No single metric tells the full story. See the BJSE:920344 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beijing Tri Prime Gene Pharmaceutical Co Business Description

Address No. 20, Jinghong Street, Biomedicine Base, Daxing District, Beijing, CHN, 102600
Beijing Tri Prime Gene Pharmaceutical Co Ltd is mainly engaged in the research, development, production, and sales of medical biotechnology products, including genetic engineering drugs, genetic engineering vaccines, and diagnostic reagents, and is engaged in related technical trade and technical consulting services. Its product line comprises Yundex Spray, Yundex Eye Drops, Yundexol Powder Injection, and Yundexol Water Injection.
77GF Score

Get the complete analysis for BJSE:920344

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥18.55
Price
¥25.94
GF Value